Psychopharmaceuticals in Dermatology
Authors:
R. Pánková
Authors place of work:
Dermatovenerologická klinika 1. LF UK a VFN
přednosta prof. MUDr. Jiří Štork, CSc.
Published in the journal:
Čes-slov Derm, 89, 2014, No. 3, p. 95-106
Category:
Reviews (Continuing Medical Education)
Summary
The importance of psychopharmacology and psychotherapy in dermatological practice is increasing. Author discusses the basic classification of psychological disorders in clinical dermatology, importance of psycho-somatic approach including a holistic approach to a man in health and illness and a context of a biopsychosocial unity of human beeing. Author shows the rules of rational prescription of psychoactive drugs, reviews the main groups of psychopharmaceuticals (anxiolotics, antidepressants, thymoleptics, hypnotics, antipsychotics and nootropic substances). Continuous development of new psychoactive drugs and complexity of dermatological psychological disorders requires interdisciplinary collaboration of dermatologists, clinical psychologists and psychiatric consultants thus enabling application of the current scientific knowledge on psycho-neuro-endocrino-immunology.
Key words:
psychodermatology – psychopharmacologics – psychoactive drugs in dermatology
Zdroje
1. AKTAN, S., OZMEN, E., SANLI, B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology, 1998, 197, p. 230–234.
2. ALTUNAY, I. K., ATES, B., MERCAN, S., DEMIRCI, G. T., KAYAOGLU, S. Variable clinical presentations of secondary delusional infestation: an experience of six cases from a psychodermatology clinic. Int. J. Psychiatry Med., 2012, 44, 4, p. 335–350.
3. ANDERS, M., MOHR, P. Léčba psychických poruch u somaticky nemocných. Farmakoterapie. In Herman, E., Praško, J., Seifertová, D. a kol. Konziliární psychiatrie. 1. vydání. Medical Tribune, 2007, s. 236–243. ISBN 978-80-903708-9-0, Galén SBN 978-80-7262-498-0.
4. BLISS, S. A., WARNOCK, J. K. Psychiatric medications: Adverse cutaneous drug reactions. Clinics in Dermatology, 2013, 31, p. 101–109.
5. BOYD, A. S., RITCHIE, C., LIHARI, S. Munchhausen syndrome and Munchhausen syndrome by proxy in dermatology. J. Am. Acad. Dermatol., 2014. Dostupné na www: http://dx.doi.org/10.1016/j.jaad.2013.12.028.
6. CHROMÝ, K., HONZÁK, R. et al. Somatizace a funkční poruchy. Grada Publishing, Praha, 2005, s. 216.
7. CHROMÝ, K. Dysmorfofobie. In Chromý, K., Honzák, R. et al. Somatizace a funkční poruchy. Grada Publishing, 2005, s. 69–75.
8. DREVETS, W. C., PRICE, J. L., FUREY, M. L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry model sof depression. Brain Struct. Funct., 2008, 213, p. 93–118.
9. FIRDAUS, S., DHABHAR, P. Psychological stress and immunoprotection versus immunopathology in the skin. Clinics in Dermatology, 2013, 31, p.18–30.
10. FRIED, R. G. Nonpharmacologic treatments in psychodermatology. Dermatol. Clin., 2002, 20, 1, p. 177–185.
11. GIELER, U., HARTH, W. Psychodermatologie. Hautarzt, 2008, 59, p. 287–288.
12. GORDON-ELLIOTT, J. S., MUSKIN, P. R. Managing the patient with psychiatric issues in dermatologic practice. Clinics in Dermatology, 2013, 31, p. 3–10.
13. GUPTA, M. A., GUPTA, A. K. Sleep-wake disorders and dermatology. Clinics in Dermatology, 2013, 31, p. 118–126.
14. GUPTA, M. A., GUPTA, A. K. Evaluation of cutaneous body image dissatisfaction in the dermatology patient. Clinics in Dermatology, 2013, 31, p. 72–79.
15. GUPTA, M. A., GUPTA, A. K. The use of antidepressant drugs in dermatology. JEADV, 2001, 15, p. 512–518.
16. GUPTA, M. A. Emotional regulation, dissociation, and the self-induced dermatoses: Clinical features and implications for treatment with mood stabilizers. Clinics in Dermatology, 2013, 31, p. 110–117.
17. HARTH, W., Gieler, U., Kunir, D., TAUSK, F. A. Clinical Management in Psychodermatology. Springer Verlag Berlin Germany, 2009, p. 195–208.
18. HAUTMANN, G., LOTTI, T. Psychoactive drugs and skin. European Academy of Dermatology and Venereology. JEADV, 2003, 17, p. 383–393.
19. HELLER, M. M., KOO, J. Y. Neurotic excoriations acne excoriee and factitial dermatitis (2011) Contemporary Diagnosis and Management in Psychodermatology. In Heller, M. M., Koo, J. Y. 1st ed. Newton: Handbooks in Health Care C.o. p. 37–44.
20. HONZÁK, R. Behaviorální medicína. In HOESCHL et al. Psychiatrie, 2. vyd. TIGIS, 2004, s. 606–608.
21. JAFFARANY, M. Lithium and skin: Dermatologic manifestations of lithium therapy. International Journal of Dermatology, 2008, 47, 11, p. 1101–1111.
22. JAFFARANY, M. Psychodermatology: A guide to understanding common psychocutaneeous disorders. Prim. Care Companion J. Clin. Psychiatry, 2007, 9, p. 201–213.
23. KASPARIAN, N. A. Psychological stress and melanoma: Are we meeting our patients’ psychological needs? Clinics in Dermatology, 2013, 31, p. 41–46.
24. KOBLENZER, C. S. Dermatitis artefacta: Clinical features and approaches to treatment. American Journal of Clinical Dermatology, 2000, 1, p. 47–55.
25. KOO, J., LEE, C. S. General Approach to Evaluating in Psychodermatological Medicine. In Koo, J., Lee, C. S. (Eds.) Psychocutaneous Medicine. New York, Marcel Deker, 2003, p. 1–12.
26. KOO, J. Psychodermatology: A practical manual for clinicians. Curr. Probl. Dermatol., 1995, 7, 6, p. 204–232.
27. KOO, J., LEE, C. S. Comprehensive dermatologic drug therapy: psychotropic agents. Philadelphia: WB Saunders Co, 2001, p. 402–425.
28. KOUKOLÍK, F. Základy kognitivní, afektivní a sociální neurovědy XXV. O štěstí – hédonický mozek. Prakt. Lék, 2013, 93, 1, s. 10–15.
29. KRASOWSKA, D., SZYMANEK, M., SCHWARTZ, R. A., MYSLINSKI, W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J. Am. Acad. Dermatol., 2007, 56, p. 848–853.
30. KRECHLEROVÁ, M., PÁNKOVÁ, R. Psychofarmaka v dermatologii. Část I. Čes.-slov. Derm., 1989, 64, s. 339–349.
31. KUKLOVÁ, I., PÁNKOVÁ, R. Psychoterapie v dermatovenerologii. Čes.-slov. Derm., 1994, 69, s. 214–215.
32. LEE, C. S., KOO, J. The use of psychotropic medications in dermatology. In Koo, J. Y. M., Lee, C. S. Psychocutaneous Medicine. Marcel Dekker, NY, USA, 2003, p. 427–451.
33. LEE, E., MURASE, J., KOO, J., LEE, C. S. Psychofarmacology in Dermatological Practice: A Review and Update. Dermatol. Psychosom., 2003, 4, p. 131–140.
34. LOWRY, C. L., BEWLEY, A., TAYLOR, R. Facial ulcer treated with olanzapine. Clinical and Experimental Dermatology, 2013, 38, 5, p. 504–506.
35. MOHANDAS, P., BEWLEY, A., TAYLOR, R. Dermatitis artefacta and artefactual skin disease: The need for a psychodermatology multidisciplinary team to treat a difficult condition. British Journal of Dermatology, 2013, 169, 3, p. 600–606.
36. NAKANO, Y. Stress-induced modulation of skin immune function: two-types of antigene-pressenting cells in the epidermis are differentially regulated by chronic stress. Br. J. Dermatol., 2004, 151, p. 50–64.
37. ORRINGER, J. S, HELFRICH, Y. R., HAMILTON, T. et al. Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. J. Am. Acad. Dermatol., 2006, 54, p. 416-419.
38. PANCONESI, E. Dermatologically expressed psychiatric syndromes. Clin. Dermatol., 1984, 2, p. 205–206.
39. PANCONESI, E. Psychosomatics factors in dermatology: Special perspectives for application in clinical practice. Dermatol. Clin., 2006, p. 639–633.
40. PÁNKOVÁ, R., BALCAR, K. Psychosomatika v dermatologii. In Novotný, F. et al. Obecná dermatologie. Praha, Avicenum, 1989, s. 266–270.
41. PÁNKOVÁ, R., MALÁ, H. K problematice tzv. neurotických exkoriací. Čes.-slov. Derm., 1979, 54, s. 271–273.
42. PÁNKOVÁ, R. Psychosomatické přístupy v dermatovenerologii. Čas. lék. čes., 2006, 145, s. 112–115.
43. PÁNKOVÁ, R., TARABA, P. Psychodermatologie a psychosomatický přístup: psycho- neuro-endokrino-imuno-dermatologie. Čes.-slov. Derm., 2007, 82, 1, s. 5–11.
44. PÁNKOVÁ, R. Diferenciální diagnostika pruritu. Čes.-slov. Derm., 2012, 87, 4, s. 127–133.
45. PÁNKOVÁ, R. Psychické poruchy u venerických pacientů. Česká derm., 2011, 1, 1, s. 45–48.
46. PAPEŽOVÁ, H. Úzkostné a somatoformní poruchy. Psychiatrie pro všeobecné praktické lékaře. RAABE, 2011, s. 34–47.
47. PARK, K. K., KOO, J. Use of psychotropic drugs in dermatology: Unique perspectives of a dermatologist and a psychiatrist. Clinics in Dermatology, 2013, 31, p. 92–100.
48. PHILIP, D., SHENEFELT, P. D. Update on psychodermatological disorders. Expert Rev. Dermatol., 2010, 5, 1, p. 95–107.
49. PICARDI, A., MELEHI, A. D. et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br. J. Dermatos., 2000, 143, p. 983–991.
50. PICARDI, A., PASQUINI, P., ABENI, D., FASSONE, G., MAZZOTI, E., FAVA, G. A. Psychosomatic assessment of skin diseases in clinical practice. Psychother. Psychosom., 2005, 74, p. 315–322.
51. PICARDI, A., LEGA, I., TAROLLA, E. Suicide risk in skin disorders. Clinics in Dermatology, 2013, 31, p. 47–56.
52. PRAŠKO, J., PÁNKOVÁ, R. Diagnostika a léčba psychických poruch v dermatologii. In Herman, E., Praško, J., Seifertová, D. a kol. Konziliární psychiatrie, 1. vydání. Medical Tribune, 2007. CZ - ISBN 978-80-903708-9-0, Galén ISBN978-80-7262-498-0.
53. POOT, F., SAMPOGNA, F., ONNIS, L. Basic knowledge in psychodermatology. JEADV, 2007, 21, p. 227–234.
54. POOT, F. What a dermatologist needs to know to transfer dermatological patients to the psychiatrist or psychologist. Dermatol. Psychosom., 2002, 3, p. 34–37.
55. POOT, F. How to be a happy dermatologist. Dermatol. Psychosom., 2004, 5, p. 112–113.
56. RABOCH, J. Afektivní poruchy. In Raboch, J., Herle, P. et al. Psychiatrie pro všeobecné praktické lékaře. RAABE, 2011, s. 67–79.
57. RAUDENSKÁ, J., JAVŮRKOVÁ, A. Psychosociální aspekty smíšených dermatóz. Dermatol. pro praxi, 2011, 5, s. 201–215.
58. SEIFERTOVÁ, D., MIKLÓŠ, T., KOTRLÍKOVÁ, E. Diagnostika a léčba psychických poruch v somatické intenzivní péči. In Herman, E., Praško, J., Seifertová, D. a kol. Konziliární psychiatri. 1. vydání, 2007, Medical Tribune. CZ - ISBN 978-80-903708-9-0, Galén SBN978-80-7262-498-0.
59. SHENEFELT, P. D. Therapeutic management of psychodermatological disorders. Expert Opin. Pharmacother., 2008, 9, 6, p. 6–10.
60. SHENEFELT, P. D. Update on psychodermatological disorders. Expert Rev. Dermatol., 2010, 5, 1, p. 95–107.
64. ŠVESTKA, J. Obecná psychofarmakologie. In Hoeschl, C., Libiger, J., Švestka, J. Psychiatrie. 2. doplněné a opravené vydání. TIGIS, spol. s r.o., 2004, s. 102–124.
62. TEY, H. L., WALLENGREN, J., YOSIPOVITCH, G. Psychosomatics factors in Pruritus. Clinics in Dermatology, 2013, 31, p. 31–40.
63. VEČEŘOVÁ-PROCHÁZKOVÁ, A. Stres, deprese a somatická onemocnění z pohledu psychoneuro-imuno-endokrinologie. Psych@Som IV, 2006, 6, s. 142–144.
64. VONDRÁČEK, V. Duše a chemie. In Úvahy psychologicko-psychiatrické. Avicenum Praha, 1975, s. 246.
65. WANG, E. H., YANG, A. C. Reversible skin rash in a bipolar disorder patient on first use of lithium. Psychiatry and Clinical Neurosciences, 2013, 67, 5, p. 365.
66. WESSELY, S. C., LEWIS, G. H. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br. J. Psychiatry, 1989, 155, p. 686–691.
67. WONG, J. W., NGUYEN, T. V., KOO, J. Y. M. Primary psychiatric conditions: Dermatitis artefacta, trichotillomania and neurotic excoriations. British Journal of Dermatology, 2013, 58, 1, p. 44–48.
Štítky
Dermatology & STDs Paediatric dermatology & STDsČlánok vyšiel v časopise
Czech-Slovak Dermatology
2014 Číslo 3
Najčítanejšie v tomto čísle
- Psychopharmaceuticals in Dermatology
- Evolution of Contact Sensitivity to The European Standard Series Allergens in the Czech Republic
- Folliculotropic T-cell Lymphoma – Case Report
- Analysis of Biological Therapy of Psoriasis in Faculty Hospital Hradec Králové in 2006–2011